TY  - GEN
AU  - Furuse,Junji
AU  - Okusaka,Takuji
AU  - Kaneko,Shuichi
AU  - Kudo,Masatoshi
AU  - Nakachi,Kohei
AU  - Ueno,Hideki
AU  - Yamashita,Tatsuya
AU  - Ueshima,Kazuomi
TI  - Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma
SN  - 1349-7006
PY  - 2010///1215
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Area Under Curve
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Drug Combinations
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Liver Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Oxonic Acid
KW  - Tegafur
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1349-7006.2010.01730.x
ER  -